dosing with 2 g/kg glucose in 48-week old female WT and KO mice (n = 7 each group)
(*NICE guidelines are evidence-based recommendations from the National Institute for Health and Care Excellence for health and social care in England and Wales)
GLP-1 receptor agonists, such as exenatide, enhance insulin secretion, suppress glucagon release, slow gastric emptying, and promote satiety
Reach out to us today, and lets find the right approach for you
Manufacturer guidance recommends against use during lactation due to this evidence gap, not proven harm
No, GLP-1 medications are not controlled substances and do not appear on standard employment drug screenings, which test for substances of abuse like opioids, amphetamines, and cannabis